DAWN

Day One Biopharmaceuticals, Inc. DAWN

DAWN
Day One Biopharmaceuticals, Inc. GERN
Geron Corporation VALN
Valneva SE ARVN
Arvinas, Inc. REPL
Replimune Group, Inc. TYRA
Tyra Biosciences, Inc. RZLT
Rezolute, Inc. AVBP
ArriVent BioPharma, Inc. Common Stock ATXS
Astria Therapeutics, Inc. ERAS
Erasca, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DAWN GERN VALN ARVN REPL TYRA RZLT AVBP ATXS ERAS
6M 24.62 % -14.19 % 41.85 % 67.44 % 1.27 % 116.34 % -62.64 % -6.77 % 118.21 % 143.62 %
YTD -34.89 % -63.06 % 82.42 % -34.67 % -20.74 % 53.22 % -68.45 % -13.72 % 44.26 % 27.22 %
1Y -34.43 % -65.09 % 125.98 % -35.02 % -20.23 % 46.81 % -63.81 % -10.50 % 33.82 % 31.11 %
3Y -61.37 % -41.67 % -38.02 % -65.76 % -63.37 % 215.41 % 11.30 % 18.50 % 9.57 % -24.51 %
5Y -64.79 % -21.30 % -67.40 % -81.43 % -75.78 % -14.96 % -91.55 % 18.50 % 3.69 % -80.29 %
10Y -64.79 % -71.82 % -67.40 % -23.12 % -34.33 % -14.96 % -97.97 % 18.50 % -97.37 % -80.29 %
From the beginning -64.79 % -81.86 % -67.40 % -23.12 % -34.33 % -14.96 % -99.66 % 18.50 % -98.34 % -80.29 %

Dividend